Addiction Medicine Physicians and Care for Hepatitis C

成瘾医学医生和丙型肝炎护理

• 批准号: 6665458
• 负责人: Alain Harris Litwin
• 金额: $ 4.18万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-09-30 至 2006-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6665458
• 关键词: HIV infections; alcoholism /alcohol abuse; attitude; behavioral /social science research tag; clinical research; depression; drug addiction; health care referral /consultation; health surveys; hepatitis C; human subject; methadone; microorganism disease chemotherapy; patient care; physicians

DESCRIPTION (provided by applicant): Drug users are heavily and disproportionately affected by hepatitis C, yet they face numerous barriers to healthcare that place them at risk for substantially lower levels of hepatitis C care than non-drug users. Because of their continuous contact with individual drug users and their knowledge of and experience with the intricacies of their healthcare, physicians practicing addiction medicine are in a unique position to facilitate drug users' access to and success with hepatitis C treatment. However, no data exists to describe the knowledge, attitudes and experience of addiction medicine physicians regarding hepatitis C care for drug users. We propose to nationwide survey of over 800 physician members of the American Society of Addiction Medicine (ASAM). Non-ASAM physicians practicing medicine in methadone maintenance treatment programs New York State will also be surveyed and compared to ASAM members to determine the generalizability of findings derived from the latter cohort. The proposed study will address the following specific aims: Aim 1: To describe the knowledge of and attitudes towards eligibility guidelines for hepatitis C treatment among physicians in addiction medicine, and determine the association between these attitudes and the physicians' provision of hepatitis C treatment to DUs, either direct or by referral; Aim 2: To determine the association between provision of HIV care by physicians in addiction medicine and the provision of hepatitis C treatment to DUs, either direct or by referral; Aim 3: To determine the association between the availability of onsite primary medical care in drug treatment programs and provision of hepatitis C treatment to DUs, either direct or by referral, by physicians in addiction medicine. The survey will focus on physicians' knowledge and attitudes surrounding treatment eligibility criteria, such as duration of abstinence from drug and alcohol use and history of depression. It will query physicians about their experience with hepatitis C treatment for drug users, either by referral or by direct management themselves, and their access to treatment resources. It will also inquire about their clinical practice setting and their professional background. The proposed study will identify strengths and weaknesses in the delivery of hepatitis C healthcare by addiction medicine physicians to drug users, and it will focus on collecting data useful for the development of interventions designed to improve drug users' access to hepatitis C treatment. Data from this study will have relevance to both drug abuse treatment policy and clinical practice.

描述（由申请人提供）： 吸毒者受到丙型肝炎的严重和不成比例的影响，但他们面临着许多医疗保健障碍，使他们面临的风险大大低于非吸毒者的丙型肝炎护理水平。由于他们与个别吸毒者的持续接触以及他们对医疗保健复杂性的了解和经验，从事成瘾医学的医生处于独特的地位，可以促进吸毒者获得并成功获得丙型肝炎治疗。然而，没有数据描述成瘾医学医生对吸毒者丙型肝炎护理的知识，态度和经验。我们建议在全国范围内对美国成瘾医学会（ASAM）的800多名医生成员进行调查。非ASAM医生在美沙酮维持治疗计划纽约州行医也将进行调查，并与ASAM成员进行比较，以确定来自后者队列的结果的普遍性。拟议的研究将针对以下具体目标： 目标1：描述成瘾医学医生对丙型肝炎治疗资格指南的知识和态度，并确定这些态度与医生直接或通过转诊向DU提供丙型肝炎治疗之间的关联; 目标二：确定成瘾医学医生提供的艾滋病毒护理与直接或转诊向吸毒者提供丙型肝炎治疗之间的关联; 目标三：确定药物治疗项目中现场初级医疗服务的可用性与成瘾医学医生直接或通过转诊向DU提供丙型肝炎治疗之间的关联。 这项调查将侧重于医生对治疗资格标准的知识和态度，如戒毒和戒酒的持续时间以及抑郁症史。它将询问医生他们对吸毒者丙型肝炎治疗的经验，无论是通过转诊还是直接管理自己，以及他们获得治疗资源的机会。它还将询问他们的临床实践设置和他们的专业背景。 拟议的研究将确定成瘾医学医生向吸毒者提供丙型肝炎医疗保健的优势和弱点，并将重点收集有助于制定旨在改善吸毒者获得丙型肝炎治疗的干预措施的数据。本研究的数据将与药物滥用治疗政策和临床实践相关。